TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.21
+0.01 (0.12%)
At close: Apr 24, 2026
Market Cap657.80M -9.6%
Revenue (ttm)n/a
Net Income-24.34M
EPS-0.30
Shares Out80.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume250,693
Average Volume373,712
Open8.31
Previous Close8.20
Day's Range7.85 - 8.52
52-Week Range7.00 - 10.60
Beta-1.26
RSI51.61
Earnings DateMay 5, 2026

About TaiwanJ Pharmaceuticals

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 13
Stock Exchange Taipei Exchange
Ticker Symbol 6549
Full Company Profile

Financial Performance

Financial Statements